Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study.
about
Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations.The burden of cancer attributable to modifiable risk factors: the Australian cancer-PAF cohort consortium.Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making.No sweat: managing menopausal symptoms at work.
P2860
Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Use of Menopausal Hormone Ther ...... tional, Cross-Sectional Study.
@ast
Use of Menopausal Hormone Ther ...... tional, Cross-Sectional Study.
@en
type
label
Use of Menopausal Hormone Ther ...... tional, Cross-Sectional Study.
@ast
Use of Menopausal Hormone Ther ...... tional, Cross-Sectional Study.
@en
prefLabel
Use of Menopausal Hormone Ther ...... tional, Cross-Sectional Study.
@ast
Use of Menopausal Hormone Ther ...... tional, Cross-Sectional Study.
@en
P2093
P2860
P1433
P1476
Use of Menopausal Hormone Ther ...... tional, Cross-Sectional Study.
@en
P2093
Emily Banks
Karen Canfell
Louiza S Velentzis
Usha Salagame
P2860
P304
P356
10.1371/JOURNAL.PONE.0146494
P407
P577
2016-03-23T00:00:00Z